SGLT2is, and GLP-1 RAs in particular promote weight loss, and therefore especially may be of benefit, given that overweight and obesity is increasingly prevalent (62%) in individuals with type 1 diabetes [12]
Some researchers switch to a 3 mL reconstitution at this point for more manageable injection volumes
This issue might be of clinical interest since PLF is a major source of morbidity and mortality in patients undergoing liver resection with an incidence between 0.7 and 34% depending on the severity of the surgery 39
40 Finally, although not a warning letter, a recently issued untitled letter again points to the agencys focus on whole supply chain accountability and resiliency
Defrre S, Gonzlez-Ramos R, Lousse JC, Colette S, Donnez O, Donnez J, et al